Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maria Lozano-Rabella"'
Autor:
Xavier Matias-Guiu, Ana Vivancos, Jordi Ponce, Ignacio Melero, Alena Gros, Josep María Piulats, Carlos E De Andrea, Maria Lozano-Rabella, Jara Palomero, August Vidal, Carla Panisello, Ricky Tirtakasuma, Judit Díaz-Gómez, Daniela Grases, Helena Pasamar, Laura Arregui, Eduard Dorca Duch, Esther Guerra Fernández
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Background Despite the growing interest in immunotherapeutic interventions for endometrial cancer (EC), the prevalence, phenotype, specificity and prognostic value of tumor infiltrating lymphocytes (TILs) in this tumor type remains unclear.Methods To
Externí odkaz:
https://doaj.org/article/a6c6008c42274bd88a20c1988684f4bb
Autor:
Xavier Matias-Guiu, Alena Gros, Jared Gartner, Steven Rosenberg, Juan Martin-Liberal, Josep María Piulats, Elena Garralda, Florian Erhard, Andreas Schlosser, Irene Brana, Eva Muñoz, Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Ignacio Matos, Michael Ghosh, Francesc Canals, August Vidal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6f8b6289045e47ccb565648afe904243
Autor:
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Roc Farriol-Duran, Juan Martín-Liberal, Maria Ochoa-de-Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matías-Guiu, Irene Brana, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
Publikováno v:
Scientia
Immunogenicity; Proteogenomics Inmunogenicidad; Proteogenómica Immunogenicitat; Proteogenòmica Purpose: Tumor antigens are central to antitumor immunity. Recent evidence suggests that peptides from noncanonical (nonC) aberrantly translated proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe8c7b8c02cd12225ff5cd0e3f083be
https://hdl.handle.net/11351/9824
https://hdl.handle.net/11351/9824
Autor:
Alena Gros, Andreas Schlosser, Elena Garralda, Eva Muñoz-Couselo, Irene Brana, Xavier Matías-Guiu, Josep Maria Piulats, August Vidal, Francesc Canals, Michael Ghosh, Jared J. Gartner, Ignacio Matos, Maria Ochoa-de-Olza, Juan Martín-Liberal, Roc Farriol-Duran, Florian Erhard, Anna Yuste-Estevanez, Jara Palomero, Andrea Garcia-Garijo, Maria Lozano-Rabella
Includes a large list of all the peptides and details of the HLA-I ligands identified at =30 ALC score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665b06cb00825ffab930b6b198d5f146
https://doi.org/10.1158/1078-0432.22490704
https://doi.org/10.1158/1078-0432.22490704
Autor:
Alena Gros, Andreas Schlosser, Elena Garralda, Eva Muñoz-Couselo, Irene Brana, Xavier Matías-Guiu, Josep Maria Piulats, August Vidal, Francesc Canals, Michael Ghosh, Jared J. Gartner, Ignacio Matos, Maria Ochoa-de-Olza, Juan Martín-Liberal, Roc Farriol-Duran, Florian Erhard, Anna Yuste-Estevanez, Jara Palomero, Andrea Garcia-Garijo, Maria Lozano-Rabella
Supplementary Figure 1. Validation of HLA-I ligand tumor antigen candidates with synthetic peptides Supplementary Figure 2. Validation of selected HLA-I ligand tumor antigen candidates identified in Mel-1 and Mel-3 with isotope-labeled peptides Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03cd00b341ff3f98cd7bebb7d65399f1
https://doi.org/10.1158/1078-0432.22490695
https://doi.org/10.1158/1078-0432.22490695
Autor:
Alena Gros, Andreas Schlosser, Elena Garralda, Eva Muñoz-Couselo, Irene Brana, Xavier Matías-Guiu, Josep Maria Piulats, August Vidal, Francesc Canals, Michael Ghosh, Jared J. Gartner, Ignacio Matos, Maria Ochoa-de-Olza, Juan Martín-Liberal, Roc Farriol-Duran, Florian Erhard, Anna Yuste-Estevanez, Jara Palomero, Andrea Garcia-Garijo, Maria Lozano-Rabella
Show patient characteristics and relevant experimental information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4deca9ae6c36a7c6031e18c600d40b64
https://doi.org/10.1158/1078-0432.22490692
https://doi.org/10.1158/1078-0432.22490692
Autor:
Jara Palomero, Carla Panisello, Maria Lozano-Rabella, Ricky Tirtakasuma, Judit Díaz-Gómez, Daniela Grases, Helena Pasamar, Laura Arregui, Eduard Dorca Duch, Esther Guerra Fernández, Ana Vivancos, Carlos E de Andrea, Ignacio Melero, Jordi Ponce, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Alena Gros
Publikováno v:
Scientia
BackgroundDespite the growing interest in immunotherapeutic interventions for endometrial cancer (EC), the prevalence, phenotype, specificity and prognostic value of tumor infiltrating lymphocytes (TILs) in this tumor type remains unclear.MethodsTo b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8c4ce2f5443759b39902966b69f7e1
http://hdl.handle.net/2445/192695
http://hdl.handle.net/2445/192695
Autor:
Jara, Palomero, Carla, Panisello, Maria, Lozano-Rabella, Ricky, Tirtakasuma, Judit, Díaz-Gómez, Daniela, Grases, Helena, Pasamar, Laura, Arregui, Eduard, Dorca Duch, Esther, Guerra Fernández, Ana, Vivancos, Carlos E, de Andrea, Ignacio, Melero, Jordi, Ponce, August, Vidal, Josep Maria, Piulats, Xavier, Matias-Guiu, Alena, Gros
Publikováno v:
Journal for immunotherapy of cancer. 10(12)
Despite the growing interest in immunotherapeutic interventions for endometrial cancer (EC), the prevalence, phenotype, specificity and prognostic value of tumor infiltrating lymphocytes (TILs) in this tumor type remains unclear.To better understand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f36e2b62398fe59d2c9ea72502471c3
https://pubmed.ncbi.nlm.nih.gov/36581331
https://pubmed.ncbi.nlm.nih.gov/36581331
Autor:
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Irene Braña, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
Tumor antigens are central to antitumor immunity. Recent evidence suggests that peptides from non-canonical (nonC) aberrantly translated proteins can be presented on HLA-I by tumor cells. Here, we investigated the immunogenicity of nonC tumor HLA-I l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07cce56c8c051def5473810ffa56ff11
https://doi.org/10.1101/2022.11.07.514886
https://doi.org/10.1101/2022.11.07.514886
Autor:
Ignacio Matos, Steven A. Rosenberg, Andreas Schlosser, Irene Brana, Andrea Garcia-Garijo, Francesc Canals, Elena Garralda, Juan Martin-Liberal, August Vidal, Eva Muñoz, Maria Lozano-Rabella, Michael Ghosh, Josep M. Piulats, Jared J. Gartner, Florian Erhard, Xavier Matias-Guiu, Jara Palomero, Alena Gros
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundDespite recent advances in exome and RNA sequencing to identify tumor-rejection antigens including neoantigens, the existing techniques fail to identify the vast majority of antigens targeted by tumor-reactive cells. A growing number of stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4eebe1d396190c79bb49160b338e877
https://doaj.org/article/6f8b6289045e47ccb565648afe904243
https://doaj.org/article/6f8b6289045e47ccb565648afe904243